Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 32.28
+3.54 (12.32%)
At close: Jun 17, 2026
Pharmaids Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -117.17 | -107.77 | -79.68 | -75.56 | 1.45 |
Depreciation & Amortization | 20.27 | 24.4 | 17.25 | 0.17 | 0.08 |
Loss (Gain) From Sale of Assets | -24.84 | 0.96 | 0.2 | 0.31 | - |
Asset Writedown & Restructuring Costs | - | - | 6.23 | - | - |
Provision & Write-off of Bad Debts | - | - | 8.08 | - | - |
Other Operating Activities | -3.97 | -42.96 | -69.47 | -23.52 | -0.04 |
Change in Accounts Receivable | -20.64 | -3.89 | 23.57 | 7.01 | 2.77 |
Change in Inventory | 96.17 | -85.93 | 7.16 | 8.88 | -5.19 |
Change in Accounts Payable | -98.18 | 111.41 | -12.4 | -4.23 | -1.56 |
Change in Other Net Operating Assets | 107.79 | -36.15 | -7.14 | 46.75 | -0.11 |
Operating Cash Flow | -40.57 | -139.91 | -106.2 | -40.19 | -2.59 |
Capital Expenditures | -44.72 | -124.81 | -228.63 | -16.73 | - |
Sale of Property, Plant & Equipment | 195.85 | 2.19 | 1.47 | - | - |
Cash Acquisitions | - | - | -524.83 | - | - |
Divestitures | 76.42 | - | - | - | - |
Investment in Securities | -3.15 | - | - | -32.7 | - |
Other Investing Activities | 9.58 | 2.39 | 2.08 | - | 4.67 |
Investing Cash Flow | 233.39 | -120.24 | -749.9 | -49.43 | 4.67 |
Long-Term Debt Issued | 70.57 | 326.96 | 15.3 | - | - |
Long-Term Debt Repaid | -255.91 | -56.67 | -24.56 | - | - |
Net Debt Issued (Repaid) | -185.33 | 270.28 | -9.26 | - | - |
Issuance of Common Stock | - | - | 780.12 | 213.09 | - |
Other Financing Activities | -14.38 | -36.73 | -24.26 | - | - |
Financing Cash Flow | -199.71 | 233.56 | 776.6 | 213.09 | - |
Miscellaneous Cash Flow Adjustments | - | -0 | - | -0 | - |
Net Cash Flow | -6.89 | -26.6 | -79.5 | 123.47 | 2.07 |
Free Cash Flow | -85.29 | -264.72 | -334.82 | -56.92 | -2.59 |
Free Cash Flow Margin | -30.59% | -135.66% | -218.84% | - | -6.58% |
Free Cash Flow Per Share | -2.41 | -7.51 | -14.74 | -4.41 | -0.25 |
Cash Interest Paid | 14.38 | 17.02 | 12.37 | - | - |
Cash Income Tax Paid | - | 0.63 | - | - | - |
Levered Free Cash Flow | -136.1 | -184.11 | -302.47 | -81.6 | 3.37 |
Unlevered Free Cash Flow | -114.28 | -171.56 | -292.83 | -81.6 | 3.37 |
Change in Working Capital | 85.14 | -14.55 | 11.19 | 58.41 | -4.09 |